The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study published by Novo Nordisk and released on Thursday.
The post is from Mad Mad News
by TYR Editor
The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study published by Novo Nordisk and released on Thursday.
The post is from Mad Mad News